Key result
Study examines cardiac mesenchymal stromal cells as drivers of excess adipocytes in arrhythmogenic cardiomyopathy.
Why the study?
It remains unclear which cell type drives fibro-adipose myocardial replacement in arrhythmogenic cardiomyopathy and whether cardiac mesenchymal stromal cells contribute to excess adipocytes.
Answers are grounded in this paper and cite their sources.
Arrhythmogenic cardiomyopathy (ACM) is a genetic disorder mainly due to mutations in desmosomal genes, characterized by progressive fibro-adipose replacement of the myocardium, arrhythmias, and sudden death. It is still unclear which cell type is responsible for fibro-adipose substitution and which molecular mechanisms lead to this structural change. Cardiac mesenchymal stromal cells (C-MSC) are the most abundant cells in the heart, with propensity to differentiate into several cell types, including adipocytes, and their role in ACM is unknown. The aim of the present study was to investigate whether C-MSC contributed to excess adipocytes in patients with ACM.
No takes yet. Share an insight, caveat, or question.
Sommariva et al. (2015) studied Arrhythmogenic cardiomyopathy. Cardiac mesenchymal stromal cells (C-MSC) was evaluated on Contribution of C-MSC to excess adipocytes.
Synapse has enriched 10 related papers. Consider them for comparative context: